HR-1107-119
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Sponsored by Steve Womack (R-AR)
What it does
This bill would allow certain Department of Veterans Affairs health care professionals to deliver, distribute, or dispense controlled substance prescription drugs to veteran patients via telemedicine, without requiring an in-person medical examination first. It applies only to VA employees (not contractors) who hold an active, unrestricted state license and are acting within legitimate medical practice, and directs the VA Secretary to issue implementing regulations.
Who benefits
Veterans, particularly those in rural or underserved areas with limited access to in-person VA care, who need ongoing prescriptions for controlled substances such as certain pain, anxiety, or ADHD medications. VA telehealth providers and health professions trainees under supervision would gain expanded prescribing flexibility, and the VA system overall could reduce appointment backlogs.
Who is hurt
There is limited direct harm, though concerns could fall on veterans at risk of substance misuse if remote prescribing reduces in-person clinical oversight, and on VA contractors, who are excluded from this authority and remain subject to stricter in-person requirements. Pharmacies and DEA regulators may also face added compliance and monitoring burdens as remote controlled-substance dispensing expands.
Supporters argue
Supporters argue that many veterans, especially those in rural areas or with mobility or transportation limitations, struggle to access in-person VA appointments, and that requiring an in-person visit before prescribing needed medications like pain management or psychiatric drugs delays necessary care. They contend the bill maintains safeguards by limiting authority to VA employees with active state licenses acting for legitimate medical purposes, and preserves all existing Controlled Substances Act obligations.
Opponents argue
Opponents argue that removing the in-person examination requirement for controlled substances, including potentially addictive medications, could increase risks of misdiagnosis, overprescription, or diversion without a clinician physically assessing the patient first. They contend that telemedicine prescribing of controlled substances has historically been restricted precisely because remote evaluation makes it harder to detect drug-seeking behavior or verify patient identity, and that oversight relies heavily on regulations the Secretary has yet to write.